Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Sperian Respiratory Protection awarded VHA contract for 65,000 special configuration half-mask respirators

The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.

13 Jul 2010

Human Genome Sciences, Lonza announce commercial supply agreement for BENLYSTA

Human Genome Sciences, Inc. and Lonza today announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under regulatory review in the United States and Europe as a potential new treatment for systemic lupus erythematosus (SLE). BENLYSTA is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in 2006.

13 Jul 2010

Biomagnetics signs LOI to acquire Lanzhou Sanhuan New Technology Development

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. This expected acquisition is the first of several planned acquisitions targeted at a $1.00 share price for Biomagnetics Diagnostics' common shares.

12 Jul 2010

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.

12 Jul 2010

Devicor completes acquisition of Ethicon Endo-Surgery's Breast Care business

Devicor Medical Products, Inc., a portfolio company of GTCR, announced today that the company has completed the acquisition of Ethicon Endo-Surgery's (EES) Breast Care business. The Breast Care business sells products designed to help doctors diagnose breast cancer at early stages while minimizing patient discomfort. The business will formally be known as Mammotome, a division of Devicor Medical Products, Inc.

12 Jul 2010

Penn Pharma, Xcelience partner to market Capsugel's Xcelodose micro-dosing system technology

Penn Pharma and Xcelience, LLC today announced that the two companies have entered into a joint venture agreement to provide Capsugel's Xcelodose® precision powder micro-dosing system technology on a global basis.

12 Jul 2010

Irvine Scientific opens new Industrial Cell Culture media production facility in Tokyo, Japan

Irvine Scientific, a member of JX Holdings group, announced today the opening of a new Industrial Cell Culture media production facility in Tokyo, Japan. The new facility, located in Saitama prefecture, will manufacture the Company's cell culture media for production of biopharmaceuticals, vaccines, monoclonal antibodies and other media's used in pharmaceuticals, medicines, and research. The facility is being commissioned and validated as completely animal component free manufacturing facility.

12 Jul 2010

Accelr8 Technology completes sale of non-exclusive license for OptiChem bio-coatings

Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.

12 Jul 2010

Merck to lay off 15 percent of workers, close plants, research facilities

Drugmaker Merck announced it is closing eight research centers and eight manufacturing plants and laying off 15,000 people from its worldwide operations during the next two years because of its merger with Schering-Plough. "The restructuring is expected to save $2.7 billion to $3.1 billion in 2012, the company said. Meanwhile, the pretax cost of the initial phase of the cost-cutting program is expected to range from $3.5 billion to $4.3 billion, much of it in severance packages for employees."

9 Jul 2010

Lantheus signs new manufacturing, supply agreement with MDS Nordion for Mo-99

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that it has signed a new manufacturing and supply agreement with MDS Nordion to purchase molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m). Mo-99 is used in Lantheus Medical Imaging's TechneLite® (Technetium Tc99m Generator) generators, which are sold throughout the world, and which produce Tc-99m, a medical isotope widely used in nuclear medicine imaging.

9 Jul 2010

Merck details global restructuring program

Merck & Co., Inc., known outside the U.S. and Canada as MSD, today provided further detail on integration plans for the company's research and development, manufacturing and other business operations as part of a global restructuring program announced following the November 2009 merger of Merck and Schering-Plough.

9 Jul 2010

Merck plans to phase out Merck Frosst Centre for Therapeutic Research by end of 2010

Merck & Co., Inc., Whitehouse Station, NJ, U.S., announced today plans to phase out the Merck Frosst Centre for Therapeutic Research, located at the head office of its Canadian subsidiary in Kirkland, Québec, by the end of 2010.

9 Jul 2010

Labopharm amends debt facility agreement with Hercules Technology Growth Capital

Labopharm Inc. today announced that Hercules Technology Growth Capital, Inc. has agreed to amend Labopharm's debt facility agreement such that Hercules has extended both the period of interest-only payments on the loan and the maturity date of the loan. The amended agreement provides Labopharm with approximately $4.5 million in additional liquidity in 2010 and throughout 2011.

9 Jul 2010

Cigarette smoking declines slowly among high school students: CDC survey

The latest survey of high school smoking rates, released today by the U.S. Centers for Disease Control and Prevention, shows that the nation continues to make gradual progress in reducing youth smoking, but declines have slowed significantly since 2003 and nearly one in five high school students still smoke.

9 Jul 2010

Department of Agriculture asks consumers to discard Milky Way Farm's hard cheddar cheese

The Department of Agriculture today advised consumers who purchased aged hard cheddar cheese made with raw milk from Milky Way Farm in Troy, Bradford County, to discard the product immediately because of potential bacterial contamination. The Bureau of Food Safety has identified 20 pounds of raw milk cheddar cheese that entered the consumer market.

9 Jul 2010

WaferGen Biosystems announces closing of $7.2M registered direct offering

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced the closing of a $7.2 million registered direct offering. The amount raised includes $1 million from the Chairman and CEO, Alnoor Shivji, and approximately $500,000 in the aggregate from four other members of the board of directors of WaferGen.

9 Jul 2010

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70 degrees centigrade.

9 Jul 2010

Onda celebrates 2000th hydrophone shipment

Onda Corporation, the global leader in ultrasound measurements, celebrated the 2000th hydrophone shipment. The hallmark unit, a polymer-based HNP hydrophone, shipped to St. Jude's Medical where it is used to test the acoustic properties of their medical transducers in production.

8 Jul 2010

Jubilant Organosys Board approves amalgamation of SML & PMSL and demerger of APP business

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, today announced that the Board has approved the scheme of amalgamation and demerger. This is to enable focused growth and value realization across operating entities.

8 Jul 2010

Ranir acquires Synpart from HemCon Medical Technologies

Ranir, LLC, a leading oral care consumer products company, announced today that it has acquired Synpart Limited and Synpart AG from HemCon Medical Technologies, Inc. Synpart is a leading manufacturer and marketer of store brand oral care products in the European Community and a contract manufacturer for global branded oral care companies.

8 Jul 2010

Manufacturing News and Research

Further Reading

Sperian Respiratory Protection awarded VHA contract for 65,000 special configuration half-mask respirators

Human Genome Sciences, Lonza announce commercial supply agreement for BENLYSTA

Biomagnetics signs LOI to acquire Lanzhou Sanhuan New Technology Development

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

Devicor completes acquisition of Ethicon Endo-Surgery's Breast Care business

Penn Pharma, Xcelience partner to market Capsugel's Xcelodose micro-dosing system technology

Irvine Scientific opens new Industrial Cell Culture media production facility in Tokyo, Japan

Accelr8 Technology completes sale of non-exclusive license for OptiChem bio-coatings

Merck to lay off 15 percent of workers, close plants, research facilities

Lantheus signs new manufacturing, supply agreement with MDS Nordion for Mo-99

Merck details global restructuring program

Merck plans to phase out Merck Frosst Centre for Therapeutic Research by end of 2010

Labopharm amends debt facility agreement with Hercules Technology Growth Capital

Cigarette smoking declines slowly among high school students: CDC survey

Department of Agriculture asks consumers to discard Milky Way Farm's hard cheddar cheese

WaferGen Biosystems announces closing of $7.2M registered direct offering

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

Onda celebrates 2000th hydrophone shipment

Jubilant Organosys Board approves amalgamation of SML & PMSL and demerger of APP business

Ranir acquires Synpart from HemCon Medical Technologies

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Latest Life Science News